supp.fit

Exogenous Ketones: study protocols

33 study groups say how much Exogenous Ketones participants took a day. These are the doses the studies gave. They are not a recommendation.

Exogenous Ketones: what the research found →

Dose per serving from research

21 study groups in 13 studies say how much Exogenous Ketones participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 g to 25 g, 43% of 21 study groups.

Daily doseStudy groups
2.5 g to 5 g
2
5 g to 10 g
5
10 g to 25 g
9
25 g to 50 g
3
50 g to 100 g
2

Commonly used together

4 of 33 study groups took Exogenous Ketones with something else, but nothing that 3 or more different studies gave.

33 study groups

Study
Defining metabolic migraine with a distinct subgroup of patients with suboptimal inflammatory and metabolic markers
2023 · Investigational medicinal product (IMP) · Adults with migraine meeting ICHD-3 classification criteria
9 g12 weeks32
Effect of Exogenous Ketones as an Adjunct to Low-Calorie Diet on Metabolic Markers
2025 · racemic β-hydroxybutyrate (BHB) mineral salts (BHB) · Adults aged 18–46 years with overweight or obesity (BMI 27–35 kg/m²), without the listed metabolic or cardiovascular diseases
10 g8 weeks24
Ketone monoester attenuates oxygen desaturation during weighted ruck exercise under acute hypoxic exposure but does not impact cognitive performance
2024 · KME condition · Healthy males aged 18–35 years
573 mg/kg1 day16
Exogenous Ketosis Impairs 30-min Time-Trial Performance Independent of Bicarbonate Supplementation
2021 · KE · Highly trained male cyclists, mean age 26 ± 6 years; no stated diagnosed condition
50 g1 day12
No effect of oral ketone ester supplementation on exercise capacity in patients with McArdle disease and healthy controls: A randomized placebo-controlled cross-over study
2022 · KE drink · Adults: patients with genetically verified glycogen storage disease type V and healthy controls; ages 25–70 years
395 mg/kg1 day12
Cardiovascular and Metabolic Effects of Modulating Circulating Ketone Bodies With 1,3-Butanediol in Patients With Heart Failure With Reduced Ejection Fraction
2025 · 1,3-butanediol · Adults with heart failure with reduced ejection fraction, age 18 years or older; mean age 64 years; 75% male
500 mg/kg1 day12
Bicarbonate Unlocks the Ergogenic Action of Ketone Monoester Intake in Endurance Exercise
2021 · KE · Well-trained male cyclists, mean age 29 years; no stated diagnosed condition
65 g1 day9
Ketone Ester Supplementation Improves Some Aspects of Cognitive Function during a Simulated Soccer Match after Induced Mental Fatigue
2022 · KME · Healthy male recreational soccer players, mean age 30 ± 3 years
25 g1 day9
Tolerability and Safety of a Novel Ketogenic Ester, Bis-Hexanoyl (R)-1,3-Butanediol: A Randomized Controlled Trial in Healthy Adults
2021 · BH-BD group · Healthy adults aged 18–65 years
12.5 g4 weeks—
Exogenous Ketosis Impairs 30-min Time-Trial Performance Independent of Bicarbonate Supplementation
2021 · KE + BIC · Highly trained male cyclists, mean age 26 ± 6 years; no stated diagnosed condition
50 g1 day12
Bicarbonate Unlocks the Ergogenic Action of Ketone Monoester Intake in Endurance Exercise
2021 · KE + BIC · Well-trained male cyclists, mean age 29 years; no stated diagnosed condition
65 g1 day9
Increased cardiorespiratory stress during submaximal cycling after ketone monoester ingestion in endurance-trained adults
2021 · ketone monoester (KE) · endurance-trained adults; 10 males and 9 females
600 mg/kg1 day19
A Randomized Open-Label, Observational Study of the Novel Ketone Ester, Bis Octanoyl (R)-1,3-Butanediol, and Its Acute Effect on ß-Hydroxybutyrate and Glucose Concentrations in Healthy Older Adults
2025 · 12.5 g BO-BD beverage · Healthy community-dwelling adults aged 65 years or older, men and women, with stable chronic disease permitted
12.5 g1 day15
A Randomized Open-Label, Observational Study of the Novel Ketone Ester, Bis Octanoyl (R)-1,3-Butanediol, and Its Acute Effect on ß-Hydroxybutyrate and Glucose Concentrations in Healthy Older Adults
2025 · 25 g BO-BD beverage · Healthy community-dwelling adults aged 65 years or older, men and women, with stable chronic disease permitted
25 g1 day15
Tolerability and Acceptability of an Exogenous Ketone Monoester and Ketone Monoester/Salt Formulation in Humans
2023 · 5 g ketone monoester (KME5) · Adults aged 18–25 years with BMI 18.5–29.9 and no stated chronic disease
5 g1 day14
Tolerability and Acceptability of an Exogenous Ketone Monoester and Ketone Monoester/Salt Formulation in Humans
2023 · 10 g ketone monoester (KME10) · Adults aged 18–25 years with BMI 18.5–29.9 and no stated chronic disease
10 g1 day14
Tolerability and Acceptability of an Exogenous Ketone Monoester and Ketone Monoester/Salt Formulation in Humans
2023 · 5 g ketone monoester/salt (KMES5) · Adults aged 18–25 years with BMI 18.5–29.9 and no stated chronic disease
5 g1 day14
Tolerability and Acceptability of an Exogenous Ketone Monoester and Ketone Monoester/Salt Formulation in Humans
2023 · 10 g ketone monoester/salt (KMES10) · Adults aged 18–25 years with BMI 18.5–29.9 and no stated chronic disease
10 g1 day14
A Randomized Open-Label, Observational Study of the Novel Ketone Ester, Bis Octanoyl (R)-1,3-Butanediol, and Its Acute Effect on ß-Hydroxybutyrate and Glucose Concentrations in Healthy Older Adults
2025 · 12.5 g BO-BD powder · Healthy community-dwelling adults aged 65 years or older, men and women, with stable chronic disease permitted; subset who completed the 12-week study and re-consented
12.5 g1 day12
Low-Dose Ketone Monoester Administration in Adults with Cystic Fibrosis: A Pilot and Feasibility Study
2024 · KME · Adults aged 21–52 with cystic fibrosis, including inpatients with an acute pulmonary exacerbation and outpatients receiving standard care
20 g7 days10
A Randomized Open-Label, Observational Study of the Novel Ketone Ester, Bis Octanoyl (R)-1,3-Butanediol, and Its Acute Effect on ß-Hydroxybutyrate and Glucose Concentrations in Healthy Older Adults
2025 · 25 g BO-BD powder · Healthy community-dwelling adults aged 65 years or older, men and women, with stable chronic disease permitted; subset who completed the 12-week study and re-consented
25 g1 day9
The Effect of Novel Exogenous Ketone Supplements on Blood Beta-Hydroxybutyrate and Glucose
2024 · Ketone monoester · Healthy adults, mean age 29 ± 5 years; 42% female
10 g1 day—
Ketone monoester ingestion improves endothelial function during hyperglycemia in females with polycystic ovary syndrome
2026 · ketone monoester (KME) · Females with PCOS and age- and BMI-matched female controls; mean age 27 years in each group
482 mg/kg1 day20
Comparison of Exogenous Ketone Administration Versus Dietary Carbohydrate Restriction on Myocardial Glucose Suppression: A Crossover Clinical Trial
2022 · KE arm · Healthy adults aged 18–60 without reported cardiovascular disease
714 mg/kg1 day18
The effect of a ketone monoester drink on blood glucose and substrate oxidation in adults with metabolic syndrome and matched controls
2025 · ketone ester (KE) condition · Adults aged 18–55, including participants with metabolic syndrome and matched participants without metabolic syndrome
282 mg/kg1 day16
Acute ingestion of a ketone monoester, whey protein, or their co-ingestion in the overnight postabsorptive state elicit a similar stimulation of myofibrillar protein synthesis rates in young males: a double-blind randomized trial
2024 · KET · Healthy recreationally active males, mean age 24.2 years, without a stated diagnosed condition
360 mg/kg1 day12
A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial
2024 · KME · Adults with type 2 diabetes, mean age 59 years; 50% female
500 mg/kg1 day10
Kinetics, tolerability and safety of (R)-1,3-butanediol (S)-lactate ester (LaKe): A randomized controlled cross-over trial in adults with obesity
2026 · LaKe · Otherwise healthy adults with obesity
50 mL4 weeks10
Ingestion of an exogenous ketone monoester improves the glycemic response during oral glucose tolerance test in individuals with impaired glucose tolerance: A cross-over randomized trial
2021 · ketone ester · Japanese adults aged 20–64 with impaired glucose tolerance; 5 men and 4 women, with BMI 18.5–25.0 kg/m²
482 mg/kg1 day9
Examining the Feasibility of Prolonged Beta-Hydroxybutyrate-Containing Supplement Drink Consumption in Adults with Type 2 Diabetes: A Randomized Controlled Pilot Trial
2025 · ketone · Adults living with type 2 diabetes
30 g90 days20
Acute ingestion of a ketone monoester, whey protein, or their co-ingestion in the overnight postabsorptive state elicit a similar stimulation of myofibrillar protein synthesis rates in young males: a double-blind randomized trial
2024 · KET+PRO · Healthy recreationally active males, mean age 24.2 years, without a stated diagnosed condition
360 mg/kg1 day12
Fasting and diurnal blood ketonemia and glycemia responses to a six-week, energy-controlled ketogenic diet, supplemented with racemic R/S-BHB salts
2023 · KD + KS · Non-diabetic adults with overweight or obesity
24 g6 weeks—
Comparison of Ketogenic Diets with and without Ketone Salts versus a Low-Fat Diet: Liver Fat Responses in Overweight Adults
2021 · KD + KS · Adults aged 21–65 who were overweight or had class 1 obesity and wanted to lose weight; participants with chronic diseases were excluded.
23.6 g6 weeks12